A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight

Mol Genet Metab. 2009 Jan;96(1):50-1. doi: 10.1016/j.ymgme.2008.10.001. Epub 2008 Nov 8.

Abstract

Insulin resistance have been demonstrated in untreated patients with Gaucher type I disease. It was implied in overweight enzyme replacement therapy (ERT) treated patients with Gaucher type I disease. In present study we investigate whether insulin resistance is presented in fourteen ERT treated patients with Gaucher type I disease and without overweight in comparison to normal subjects. This work illustrates the presence of insulin resistance in non-overweight ERT treated patients with Gaucher type I disease.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / enzymology*
  • Glucosylceramidase / genetics
  • Glucosylceramidase / therapeutic use*
  • Humans
  • Insulin Resistance*
  • Male
  • Mutation
  • Overweight*
  • Pilot Projects

Substances

  • Glucosylceramidase